Pharmaceutical companies often face staff and management resistance beyond other difficulties to embrace technological innovation. Processes are established and bonded to the internal and usual practice of staff members. To no surprise, risk-based monitoring is not a different case.
Therefore, in order to make the new procedures work, it is very important to have on-board an experienced project management team that can guide you through the change-management jungle.
Cyntegrity is happy to announce a strategic partnership with PPH plus, a german CRO that provides operational and consultancy services to biopharma for the international market place (clinical trials from phase I to IV).
PPH plus represents true expertise and project leadership acumen from early planning to study report writing as well as in-depth knowledge of overall drug development. Their highly experienced team, composed of medical doctors and project leaders with scientific background, has a deep understanding about the potential risks and risk indicators in a clinical study.
Cyntegrity and PPH plus offer a top service in the application and integration of the risk-based monitoring process in biopharmaceutical companies, other service providers and academia.